Literature DB >> 9325485

HLA class I expression on the materno-fetal interface.

A Hammer1, H Hutter, G Dohr.   

Abstract

PROBLEM: The conditions that permit the genetically dissimilar (haplo-non-identical) human fetus to evade rejection by its mothers immune system have been the subject of intense interest for several years. As the placental cells, which are in contact with maternal blood or tissue, are devoid of HLA class II antigens, the interest has focused on the expression of HLA class I molecules. METHOD OF STUDY: Recent findings on the constitutive, transcriptional, and translational expression of HLA class I molecules on anatomically and morphologically different subpopulations of trophoblast cells will form the basis of this article.
RESULTS: The expression of HLA class I molecules in the trophoblast cells, forming the materno-fetal junctional zone is inhomogeneous. It differs depending on the differentiation and location of trophoblast cells within the placenta and furthermore on the stage of gestation. On the transcriptional level HLA-A, -B, -C, -E, and -G could be detected on individual trophoblast populations, whereas only HLA-C and HLA-G seem to be translated to protein.
CONCLUSIONS: The expression of HLA class I antigens by trophoblast cells is not simply suppressed. Instead, less polymorphic HLA-G and HLA-C antigens are carefully selected from the class I multigene family. This gives rise to the assumption that these two HLA class I molecules play an important role in the maintenance of pregnancy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325485     DOI: 10.1111/j.1600-0897.1997.tb00291.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  5 in total

1.  Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege.

Authors:  K Ohshima; M Nakashima; K Sonoda; M Kikuchi; T Watanabe
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.

Authors:  Masakazu Terauchi; Hideki Koi; Chikako Hayano; Noriko Toyama-Sorimachi; Hajime Karasuyama; Yuji Yamanashi; Takeshi Aso; Masaki Shirakata
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Cristiano Jodicke; Shali Mazaki-Tovi; Edi Vaisbuch; Offer Erez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Sam S Edwin; Percy Pacora; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-12

4.  Cross-Reactivity of Virus-Specific CD8+ T Cells Against Allogeneic HLA-C: Possible Implications for Pregnancy Outcome.

Authors:  Anita van der Zwan; Ellen M W van der Meer-Prins; Paula P M C van Miert; Heleen van den Heuvel; Jacqueline D H Anholts; Dave L Roelen; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

5.  Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11.

Authors:  D J Schust; D Tortorella; J Seebach; C Phan; H L Ploegh
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.